Jay S. Stout, Chief Technology Officer at Immunovant, Inc. (IMVT), sold 5,610 shares at $18.15 ($102K) on 2025-07-23, disclosed to the SEC on 2025-07-25.
Open-market sale of $102k IMVT by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.15 | 2,805 | $51K | 50.0% |
| 2 | $18.15 | 2,805 | $51K | 50.0% |
| Total | $18.15 avg | 5,610 | $102K | 100% |
| Filing → |
| IMVT | SELL | 2026-06-26 | $1.5M | — | Filing → |
| IMVT | SELL | 2026-04-24 | $82K | — | Filing → |
| IMVT | SELL | 2026-04-10 | $252K | — | Filing → |